Roberto Caporali to Rheumatic Diseases
This is a "connection" page, showing publications Roberto Caporali has written about Rheumatic Diseases.
Connection Strength
0.787
-
What is the true incidence of COVID-19 in patients with rheumatic diseases? Ann Rheum Dis. 2021 02; 80(2):e18.
Score: 0.267
-
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection. Clin Exp Rheumatol. 2021 May-Jun; 39(3):695.
Score: 0.071
-
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study. J Autoimmun. 2021 01; 116:102545.
Score: 0.069
-
Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data? Arthritis Rheumatol. 2020 10; 72(10):1600-1606.
Score: 0.069
-
COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19). Clin Exp Rheumatol. 2020 Jul-Aug; 38(4):748-753.
Score: 0.068
-
COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country. Pediatr Rheumatol Online J. 2020 Apr 22; 18(1):35.
Score: 0.067
-
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. Autoimmun Rev. 2019 Feb; 18(2):164-176.
Score: 0.061
-
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis. Autoimmun Rev. 2019 Jan; 18(1):93-106.
Score: 0.060
-
Undifferentiated connective tissue diseases and adverse pregnancy outcomes. An undervalued association? Am J Reprod Immunol. 2017 Dec; 78(6).
Score: 0.056